drugset / Trial / NCT00207090
Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to test how rifampin affects the removal of BMS-247550 (ixabepilone) from the body.
Timeline
- Start
- 2005-09
- Primary completion
- 2008-11
- Completion
- 2008-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ixabepilone | Small molecule | 40 mg/m2 | Intravenous |
| Subject | Rifampin | Small molecule | 600 mg | Oral |